The Merkel cell carcinoma disease treatment market is projected to grow at a CAGR of 3.43% during the forecast period, reaching US$4.834 billion by 2029, ...

The Gaucher disease treatment market is projected to grow at a CAGR of 2.24% during the forecast period, reaching US$1,248.479 million by 2029, from US$1,069.222 ...

The neuropathic pain market is anticipated to expand at a high CAGR over the forecast period. Neuropathic pain, a challenging and often debilitating condition, ...

The cartilage repair market is experiencing significant growth driven by the rising prevalence of joint-related disorders and injuries worldwide. Cartilage ...

The atrial septal defect market was valued at US$2.431 billion in 2022. One of the most prevalent congenital heart diseases (CHDs) and the most prevalent ...

The disruptive behavior disorder treatment market is estimated to grow at a CAGR of 5.82% during the forecast period. Disruptive behavior disorders are ...

The skeletal dysplasia market is estimated to grow at a CAGR of 3.69% during the forecast period. Osteochondrodysplasia, another name for skeletal dysplasias ...

The cystic fibrosis market was valued at US$9,291.199 million in 2022. The cells that make mucus, perspiration, and digestive fluids are impacted by cystic ...

The glaucoma treatment market was valued at US$2.047 billion in 2021. The glaucoma treatment market is anticipated to grow significantly during the forecast ...

The intravenous (IV) hydration therapy market is projected to show steady growth during the forecast period. IV hydration therapy is a medical procedure ...